Observatory of Patients With Haemophilia B Treated by IdElvion® (OrPHEe)
Sponsor: CSL Behring
This observational or N/A phase trial investigates Haemophilia B and is currently ongoing. CSL Behring leads this study, which shows 20 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
20 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting
-
Feb 2025 — Sep 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2025 — Feb 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 15 earlier versions
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Jan 2024 — May 2024 [monthly]
Recruiting
-
Nov 2023 — Jan 2024 [monthly]
Recruiting
-
Jul 2023 — Nov 2023 [monthly]
Recruiting
-
Apr 2023 — Jul 2023 [monthly]
Recruiting
-
Nov 2022 — Apr 2023 [monthly]
Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting
-
May 2022 — Jul 2022 [monthly]
Recruiting
-
Apr 2022 — May 2022 [monthly]
Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- CSL Behring
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Annecy, France , Besançon, France , Bordeaux, France , Brest, France , Caen, France , Clermont-Ferrand, France , Dijon, France , Eaubonne, France , Grenoble, France and 18 more locations